Optimal Intravenous Administration Procedure for Efficient Delivery of Canine Adipose-Derived Mesenchymal Stem Cells
Open Access
- 24 November 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (23) , 14681
Abstract
Mesenchymal stem cells (MSC) are currently being investigated for their therapeutic applications in a wide range of diseases. Although many studies examined peripheral venous administration of MSC, few have investigated the detailed intravenous administration procedures of MSC from their preparation until they enter the body. The current study therefore aimed to explore the most efficient infusion procedure for MSC delivery by preparing and infusing them under various conditions. Canine adipose-derived mesenchymal stem cells (cADSC) were infused using different infusion apparatuses, suspension solutions, allogenic serum supplementation, infusion time and rates, and cell densities, respectively. Live and dead cell counts were then assessed by manual measurements and flow cytometry. Efficiency of live- and dead-cell infusion and cell viability were calculated from the measured cell counts and compared under each condition. Efficiency of live-cell infusion differed significantly according to the infusion apparatus, infusion rate, and combination of cell density and serum supplementation. Cell viability after infusion differed significantly between the infusion apparatuses. The optimal infusion procedure resulting in the highest cell delivery and viability involved suspending cADSC in normal saline supplemented with 5% allogenic serum at a density of 5 × 105 cells/mL, and infusing them using an automatic infusion device for 15 min. This procedure is therefore recommended as the standard procedure for the intravenous administration of ADSC in terms of cell-delivery efficiency.Keywords
Funding Information
- JSPS KAKENHI (JP21H02373)
This publication has 77 references indexed in Scilit:
- Mesenchymal Stem Cells from Human Umbilical Cord Express Preferentially Secreted Factors Related to Neuroprotection, Neurogenesis, and AngiogenesisPLOS ONE, 2013
- Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studiesStem Cell Research & Therapy, 2013
- Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indicationsJournal of Translational Medicine, 2012
- The Effect of Transcatheter Injections on Cell Viability and Cytokine Release of Mononuclear CellsAmerican Journal of Neuroradiology, 2010
- Effect of Needle Diameter and Flow Rate on Rat and Human Mesenchymal Stromal Cell Characterization and ViabilityTissue Engineering Part C: Methods, 2010
- Novel Culture System of Mesenchymal Stromal Cells from Human Subcutaneous Adipose TissueStem Cells and Development, 2009
- Temperature and calcium ions affect aggregation of mesenchymal stem cells in phosphate buffered salineCytotechnology, 2008
- Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantationJournal of Tissue Engineering and Regenerative Medicine, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Autologous mesenchymal stem cell transplantation in stroke patientsAnnals of Neurology, 2005